BSECorp Action24 Aug 2026 · 24 Aug 2026, 06:01 pm

Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on August 24, 2026.

Advanced Enzyme Technologies Ltd · 540025

✦ AI SummaryBuyback

Advanced Enzyme Technologies Ltd has submitted a daily report under Regulation 18(i) of the Buyback Regulations regarding the equity shares bought back on August 24, 2026. The company has bought 40,876 equity shares through Emkay Global Financial Services Limited at an average price of ₹302.7754.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk4/10
Liquidity Impact6/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares

Attachments (1)

📄

6d1d415c-5253-4dae-ae21-d9884469def3.pdf

pdf

Download →
View document text
August 24, 2026 The Listing Department The Listing Department BSE Limited National Stock Exchange of India Limited 1st Floor, New Trading Ring, Rotunda Building, P.J. Exchange Plaza, Plot No. C/1, G Block Towers, Bandra-Kurla Complex, Dalal Street, Fort, Mumbai — 400 001 Bandra (East), Mumbai- 400 051 Scrip Code: 540025 Symbol: ADVENZYMES Dear Sir/ Madam, Sub: Buyback by Advanced Enzyme Technologies Limited (“Company”) of its fully paid-up Equity Shares of face value of ₹ 2/- each (Rupees Two only) (“Equity Share(s)”) from the open market through stock exchanges mechanism pursuant to the provisions of the SEBI (Buy-Back of Securities) Regulations, 2018 as amended (“Buyback Regulations”). With reference to the captioned matter, the Company hereby submits the daily report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on August 24, 2026: Name of the Broker Number of Equity Shares bought Total Equity Average Price back on August 24, 2026 Shares bought of acquisition BSE NSE MSEI back (A) (₹)* Emkay Global Financial NIL 40,876 N.A. 40,876 302.7754 Services Limited Cumulative Equity Shares bought as on Yesterday (B) (i.e. till August 21, 2026) 5,18,668 Less: Quantity Closed Out Today (C) 0 Quantity Closed Out as on Yesterday (D) 0 Total Quantity closed out (C+D=E) 0 Total Equity Shares bought back as on August 24, 2026 (A)+(B) - (E) 5,59,544 *Excludes Transaction Cost; N.A. – Not applicable The details will also be made available on the website of the Company at www.advancedenzymes.com and on the websites of the stock exchanges where the shares of the Company are listed at www.bseindia.com and www.nseindia.com. Capitalized terms used and not defined herein shall have the meaning ascribed to them in the Public Announcement. This is for your information and records. Yours faithfully For Advanced Enzyme Technologies Limited Sanjay Basantani Company Secretary and Head-Legal Membership No.: A19637